sodium salicylate has been researched along with endothelin-1 in 2 studies
| Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (endothelin-1) | Trials (endothelin-1) | Recent Studies (post-2010) (endothelin-1) |
|---|---|---|---|---|---|
| 2,031 | 50 | 171 | 12,740 | 632 | 3,394 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallois, C; Habib, A; Lotersztajn, S; Maclouf, J; Mallat, A; Moulin, S; Tao, J | 1 |
| Berkane, N; Blandin, V; Breittmayer, JP; Ferrari, E; Frelin, C; Talbodec, A; Vigne, P | 1 |
2 other study(ies) available for sodium salicylate and endothelin-1
| Article | Year |
|---|---|
Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.
Topics: Adipocytes; Antineoplastic Agents; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dexamethasone; Dimerization; DNA-Binding Proteins; Endothelin-1; Fibroblasts; Humans; I-kappa B Proteins; Isoenzymes; Leupeptins; Liver; Membrane Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Receptor, Endothelin B; Receptors, Endothelin; Sodium Salicylate; Tumor Necrosis Factor-alpha; Up-Regulation; Viper Venoms | 1998 |
Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism.
Topics: Allosteric Regulation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta; Aspirin; Biological Transport; Bosentan; Calcium; Cells, Cultured; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Humans; Mammary Arteries; Muscle Contraction; Rats; Receptors, Endothelin; Sodium Salicylate; Sulfonamides | 2000 |